QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:EXPI

eXp World (EXPI) Stock Forecast, Price & News

$16.69
+0.26 (+1.58%)
(As of 06/7/2023 ET)
Compare
Today's Range
$16.55
$17.06
50-Day Range
$11.07
$16.43
52-Week Range
$9.96
$18.70
Volume
682,294 shs
Average Volume
806,985 shs
Market Capitalization
$2.56 billion
P/E Ratio
333.87
Dividend Yield
1.08%
Price Target
$14.00

eXp World MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
16.1% Downside
$14.00 Price Target
Short Interest
Bearish
16.85% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.28mentions of eXp World in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$3.38 M Sold Last Quarter
Proj. Earnings Growth
113.04%
From $0.23 to $0.49 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

Finance Sector

734th out of 850 stocks

Real Estate Agents & Managers Industry

10th out of 13 stocks


EXPI stock logo

About eXp World (NASDAQ:EXPI) Stock

eXp World Holdings, Inc. operates as a cloud-based real estate brokerage firm. It focuses on the development and use of cloud-based technologies in order to grow an international brokerage without the burden of physical brick and mortar offices and redundant staffing costs. The firm offers software subscriptions to customers to access its virtual reality software platform through VirBELA. The company was founded by Glenn Darrel Sanford on July 30, 2008 and is headquartered in Bellingham, WA.

Receive EXPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for eXp World and its competitors with MarketBeat's FREE daily newsletter.

EXPI Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
eXp Realty Launches Military Rewards Program
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
eXp World (EXPI) Q1 2023 Earnings Call Transcript
eXp World Holdings Reports Q1 2023 Results
See More Headlines

EXPI Price History

EXPI Company Calendar

Ex-Dividend for 3/31 Dividend
3/10/2023
Dividend Payable
3/31/2023
Last Earnings
5/02/2023
Ex-Dividend for 5/31 Dividend
5/11/2023
Dividend Payable
5/31/2023
Today
6/07/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate agents & managers
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:EXPI
Previous Symbol
NASDAQ:EXPI
Fax
N/A
Employees
2,016
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.00
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
-16.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$15.44 million
Pretax Margin
-0.01%

Debt

Sales & Book Value

Annual Sales
$4.60 billion
Cash Flow
$0.18 per share
Book Value
$1.63 per share

Miscellaneous

Free Float
99,860,000
Market Cap
$2.56 billion
Optionable
Not Optionable
Beta
2.71

Key Executives

  • Glenn Darrel SanfordGlenn Darrel Sanford
    Chairman, Chief Executive Officer & Treasurer
  • Patrick O’Neill
    Chief Operating Officer
  • Jeff Whiteside
    Chief Financial & Collaboration Officer
  • Shoeb Ansari
    Chief Information Officer
  • Jason GesingJason Gesing
    Director & Chief Industry Relations Officer













EXPI Stock - Frequently Asked Questions

Should I buy or sell eXp World stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for eXp World in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" EXPI shares.
View EXPI analyst ratings
or view top-rated stocks.

What is eXp World's stock price forecast for 2023?

2 brokers have issued 1-year price targets for eXp World's stock. Their EXPI share price forecasts range from $14.00 to $14.00. On average, they expect the company's stock price to reach $14.00 in the next year. This suggests that the stock has a possible downside of 16.1%.
View analysts price targets for EXPI
or view top-rated stocks among Wall Street analysts.

How have EXPI shares performed in 2023?

eXp World's stock was trading at $11.08 at the start of the year. Since then, EXPI stock has increased by 50.6% and is now trading at $16.69.
View the best growth stocks for 2023 here
.

When is eXp World's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our EXPI earnings forecast
.

How were eXp World's earnings last quarter?

eXp World Holdings, Inc. (NASDAQ:EXPI) issued its quarterly earnings data on Tuesday, May, 2nd. The technology company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.07. The technology company earned $850.62 million during the quarter, compared to analyst estimates of $861.21 million. eXp World had a net margin of 0.18% and a trailing twelve-month return on equity of 3.15%. The firm's revenue for the quarter was down 15.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.06 EPS.

How often does eXp World pay dividends? What is the dividend yield for eXp World?

eXp World declared a quarterly dividend on Thursday, April 27th. Stockholders of record on Friday, May 12th will be given a dividend of $0.045 per share on Wednesday, May 31st. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date of this dividend is Thursday, May 11th.
Read our dividend analysis for EXPI
.

Is eXp World a good dividend stock?

eXp World (NASDAQ:EXPI) pays an annual dividend of $0.18 per share and currently has a dividend yield of 1.16%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 360.07%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, EXPI will have a dividend payout ratio of 36.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPI.

When did eXp World's stock split?

eXp World's stock split on the morning of Tuesday, February 16th 2021. The 2-1 split was announced on Tuesday, January 19th 2021. The newly created shares were issued to shareholders after the market closes on Friday, February 12th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Jason Gesing's approval rating as eXp World's CEO?

558 employees have rated eXp World Chief Executive Officer Jason Gesing on Glassdoor.com. Jason Gesing has an approval rating of 96% among the company's employees. This puts Jason Gesing in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 94.0% of employees surveyed would recommend working at eXp World to a friend.

What other stocks do shareholders of eXp World own?

Based on aggregate information from My MarketBeat watchlists, some companies that other eXp World investors own include Tesla (TSLA), NVIDIA (NVDA), ServiceNow (NOW), Walt Disney (DIS), Intel (INTC), Block (SQ), Advanced Micro Devices (AMD), DocuSign (DOCU), Teladoc Health (TDOC) and General Electric (GE).

What is eXp World's stock symbol?

eXp World trades on the NASDAQ under the ticker symbol "EXPI."

Who are eXp World's major shareholders?

eXp World's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.32%), Copeland Capital Management LLC (2.97%), Integrated Advisors Network LLC (1.26%), Geode Capital Management LLC (1.06%), Renaissance Technologies LLC (0.97%) and State Street Corp (0.92%). Insiders that own company stock include Courtney Keating Chakarun, Daniel Cahir, Darren Lee Jacklin, Eugene Frederick, Glenn Darrel Sanford, James Bramble, Jason Gesing, Jeff Whiteside, Jian Cheng, John K Tobison, Jose Enrique Valdes, Penny Sanford, Randall D Miles, Randall D Miles and Stacey Onnen.
View institutional ownership trends
.

How do I buy shares of eXp World?

Shares of EXPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is eXp World's stock price today?

One share of EXPI stock can currently be purchased for approximately $16.69.

How much money does eXp World make?

eXp World (NASDAQ:EXPI) has a market capitalization of $2.56 billion and generates $4.60 billion in revenue each year. The technology company earns $15.44 million in net income (profit) each year or $0.05 on an earnings per share basis.

How many employees does eXp World have?

The company employs 2,016 workers across the globe.

How can I contact eXp World?

eXp World's mailing address is 2219 RIMLAND DR. SUITE 301, BELLINGHAM WA, 98226. The official website for the company is expworldholdings.com. The technology company can be reached via phone at (360) 685-4206 or via email at investors@expworldholdings.com.

This page (NASDAQ:EXPI) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -